Correlation Between Biomarin Pharmaceutical and Alpha Tau

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Alpha Tau at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Alpha Tau into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Alpha Tau Medical, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Alpha Tau and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Alpha Tau. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Alpha Tau.

Diversification Opportunities for Biomarin Pharmaceutical and Alpha Tau

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Biomarin and Alpha is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Alpha Tau Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alpha Tau Medical and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Alpha Tau. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alpha Tau Medical has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Alpha Tau go up and down completely randomly.

Pair Corralation between Biomarin Pharmaceutical and Alpha Tau

Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Alpha Tau. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 1.93 times less risky than Alpha Tau. The stock trades about -0.05 of its potential returns per unit of risk. The Alpha Tau Medical is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  463.00  in Alpha Tau Medical on October 4, 2024 and sell it today you would lose (153.00) from holding Alpha Tau Medical or give up 33.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biomarin Pharmaceutical  vs.  Alpha Tau Medical

 Performance 
       Timeline  
Biomarin Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomarin Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Biomarin Pharmaceutical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Alpha Tau Medical 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Alpha Tau Medical are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Alpha Tau unveiled solid returns over the last few months and may actually be approaching a breakup point.

Biomarin Pharmaceutical and Alpha Tau Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomarin Pharmaceutical and Alpha Tau

The main advantage of trading using opposite Biomarin Pharmaceutical and Alpha Tau positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Alpha Tau can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpha Tau will offset losses from the drop in Alpha Tau's long position.
The idea behind Biomarin Pharmaceutical and Alpha Tau Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk